AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$CLBT

Jewell Marcus sold $141K of CLBT

Jewell Marcus (Global Chief Revenue Officer) sold 12,562 shares of Cellebrite DI Ltd. (CLBT) at $11.24 ($0.14M total) on 2026-08-21.

Original reporting
SEC EDGAR · Jewell Marcus
Published Aug 24, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CLBT
Neutral
high confidence
Mentioned
$CLBT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLBTNeutralLow
01

Why it matters

The CRO's sale represents a routine liquidity event; unlikely to move the stock significantly.

02

Market read

Minor insider sell with limited impact on price or sector.

03

What to watch

Potential upcoming product announcements or contract wins could offset any negative sentiment.

Relevance 4/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions; investors monitor sales by senior executives for signals.

Company-level read

Ticker impact

$CLBTNeutralHigh confidence
Context

Cellebrite CRO Jewell Marcus sold 12,562 shares for $141,216, a Form 4 insider sale disclosed on 2026-08-24.

Expected impact

Potential slight downward pressure, likely negligible.

Evidence & confidence

Sale size is small relative to holdings and market cap; no broader implications.

Market effects

Sector

None; insider sale does not affect the broader digital forensics sector.

Regional

None; limited to Cellebrite shareholders.

Global

Minimal; no macro or sector-wide effect.

Counterpoint

What could challenge this read

The sale could signal insider concern, but size is too small to infer material risk.

Key entities

  • Company
    Cellebrite DI Ltd.

    Provider of digital intelligence solutions, ticker CLBT.

  • Executive
    Jewell Marcus

    Global Chief Revenue Officer of Cellebrite.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CLBT insider trading history →

Related articles

$CLBTHighAI 8/10

Cellebrite DI Ltd. (CLBT): Financial results for Q3 2026

Cellebrite DI Ltd. (CLBT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Cellebrite Reports Third-Quarter 2026 Results Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, VA and

SEC EDGAR 6-K
$CLBTHigh

Cellebrite Reports Third-Quarter 2026 Results

Cellebrite reported Q3 2026 results with ARR up 20% to $528.5M, revenue up 18% to $149M, and adjusted EBITDA of $53.6M. CEO Shiv Ramji highlighted strong international and U.S. Federal performance, and raised 2026 adjusted EBITDA outlook to $163M-$166M. The company also announced plans to redomicile in the U.S. and progress with its Genesis AI solution.

prnewswire.com
$CLBTMedAI 8/10

Cellebrite (CLBT) Q2 2026 Earnings Call Transcript

Cellebrite (CLBT) announced Shiv Ramji as its new CEO, replacing Tom Hogan. The company missed Q2 revenue expectations due to delayed large transactions and lower-than-expected ARR uplift. Despite this, they raised their full-year adjusted EBITDA target. Ramji outlined plans to improve sales execution and forecasting discipline. The company sees growth in new products and federal business, with a 25% increase in Defense and Intelligence ARR.

yahoo.com